REG - Surgical Innovations - Director/PDMR Shareholding

Surgical InnovationsAnnouncement

11/09/2018 10:25

RNS Number : 4103A
Surgical Innovations Group PLC
11 September 2018
 


Surgical Innovations Group plc
("the Company")
Director/PDMR Shareholdings
The Company was notified on 11 September 2018 that on 11 September 2018 Nigel Rogers, Executive Chairman, purchased 416,830 ordinary shares of 1 penny each in the Company ("Shares") for his ISA at a price of 3.25p per Share in an off-market transaction from Hardy Transaction Management Limited, which is wholly owned by Paul Hardy, a Non-Executive Director of the Company.
Following the transaction, the aggregate beneficial holding of Nigel Rogers in the Company is 6,276,830 Shares, representing 0.80% of the issued share capital and the beneficial holding of Paul Hardy is 5,808,711 Shares, representing 0.74% of the issued share capital.
For further information please contact:




Surgical Innovations Group plc


www.sigroupplc.com




Nigel Rogers, Executive Chairman


Tel: 0113 230 7597




Melanie Ross, COO & CFO
 


 




WH Ireland Limited (NOMAD & Broker)


Tel: 0113 394 6600




Tim Feather
Chris Viggor
 


 




Walbrook PR (Financial PR & Investor Relations)


Tel: 020 7933 8780 or si@walbrookpr.com




Paul McManus


Mob: 07980 541 893




Lianne Cawthorne


Mob: 07584 391303




NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Nigel Rogers




2


Reason for the notification




a)


Position/status


Executive Chairman




b)


Initial notification/ Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Surgical Innovations Group plc




b)


LEI


2138004GHGUH3HUZE156

 




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
 
Identification code


Ordinary shares of 1p each
 
 
GB0004016704




b)


Nature of the transaction


Purchase of ordinary shares




c)


Price(s) and volume(s)






Price(s)


Volume(s)




3.25 pence


416,830




 




d)


Aggregated information
-     Aggregated volume
-     Price


 
 
416,830
3.25 pence




e)


Date of the transaction


11 September 2018




f)


Place of the transaction


Off-market




 




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Paul Hardy




2


Reason for the notification




a)


Position/status


Non-Executive Director




b)


Initial notification/ Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Surgical Innovations Group plc




b)


LEI


2138004GHGUH3HUZE156

 




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
 
Identification code


Ordinary shares of 1p each
 
 
GB0004016704




b)


Nature of the transaction


Sale of ordinary shares




c)


Price(s) and volume(s)






Price(s)


Volume(s)




3.25 pence


416,830




 




d)


Aggregated information
-     Aggregated volume
-     Price


 
 416,830 ordinary shares
3.25 pence




e)


Date of the transaction


11 September 2018




f)


Place of the transaction


Off-market




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGCGDCDDBBGIB